Mechanical circulatory support with implantable durable continuous-flow left ventricular
assist devices (CF-LVADs) represents an established surgical treatment option for patients …

Over the last two decades, implantable continuous flow left ventricular assist devices (LVAD)
have proven to be invaluable tools for the management of selected advanced heart failure …

Aims Mitral valve regurgitation (MR) is common in patients with advanced heart failure (HF).
Percutaneous mitral valve repair (PMVR) via MitraClip (MC) has emerged as a feasible …

Background Left ventricular assist devices (LVADs) represent an important therapeutic
option for patients progressing to end‐stage heart failure. LVAD has previously been shown …

Background Mitral valve regurgitation (MR) is a common finding in patients with end‐stage
heart failure. The aim of the study was to analyze the impact of preoperative moderate‐to …

Background: Donor shortage limits the utilization of heart transplantation, making it available
for only a fraction of the patients on the transplant waiting list. Therefore, continuous-flow left …

Significant mitral regurgitation (MR) is a frequent manifestation of advanced heart failure and
has been associated with a worse prognosis. 1, 2 Functional MR is the most common mitral …

Since the time of their invention, implantable continuous flow left ventricular assist devices
(LVADs) have improved the quality of life and extended survival for patients with advanced …

Innovations in left ventricular assist devices (LVADs) have revolutionized the treatment of
advanced heart failure. 1, 2 However, accurate outcome prognostication is limited in the …

Patients with advanced heart failure often have functional mitral regurgitation. Left
ventricular assist device implantation improves functional mitral regurgitation through left …